Skip to main content
. 2023 Jun 12;15(6):e40283. doi: 10.7759/cureus.40283

Table 2. Mode of detection of recurrence during NMIBC surveillance.

Data are presented as numbers (percent).

NMIBC: non-muscle invasive bladder cancer.

  n
Total recurrences 95
Cystoscopy positive/cytology negative 62 (65.3)
Cystoscopy negative/cytology positive 3 (3.2)
Cystoscopy positive/cytology positive 14 (14.7)
Cystoscopy negative/cytology negative 14 (14.7)
Incidental finding 2 (2.1)